Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | GFER | P55789 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYBB | P04839 | 1/20 | 0.37 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20739825 | 0.84 | LMNA (0.54) | LMNAALDH1A1L3MBTL1PDGFRBMEN1 | |
| SCHEMBL21972259 | 0.83 | LMNA (0.58) | LMNAALDH1A1L3MBTL1PDGFRBMEN1 | |
| SCHEMBL21971404 | 0.82 | LMNA (0.58) | LMNAALDH1A1PDGFRBMEN1KMT2A | |
| SCHEMBL21972266 | 0.79 | LMNA (0.49) | LMNAALDH1A1L3MBTL1PDGFRBMEN1 | |
| SCHEMBL21970634 | 0.76 | LMNA (0.59) | LMNAALDH1A1PDGFRBMEN1KMT2A | |
| SCHEMBL21972251 | 0.76 | LMNA (0.49) | LMNAALDH1A1PDGFRBMEN1KMT2A | |
| SCHEMBL21972257 | 0.76 | LMNA (0.49) | LMNAALDH1A1L3MBTL1PDGFRBMEN1 | |
| SCHEMBL21972258 | 0.72 | LMNA (0.46) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL20739824 | 0.72 | LMNA (0.36) | LMNAALDH1A1PDGFRBKDM4EBRPF1 | |
| SCHEMBL3423280 | 0.70 | ALDH1A1 (0.44) | LMNAALDH1A1L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046655-B2 | Compound and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-29 | — | — | US | disclosed |
| EP-3416205-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10711091-B2 | Light-emitting device and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20200140394-A1 | NOVEL COMPOUND AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-07 | — | — | US | disclosed |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711091-B2 | Light-emitting device and method for producing same | SCO2, SUN2, SLC18A2 | LMNA 919/4885ALDH1A1 327/4885L3MBTL1 1432/4885 |
| US-20200140394-A1 | NOVEL COMPOUND AND METHOD FOR PRODUCING SAME | CBR3, NR2E3, NR5A2 | LMNA 4733/4885ALDH1A1 1147/4885L3MBTL1 2731/4885 |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | SCO2, SUN2, SLC18A2 | LMNA 919/4885ALDH1A1 327/4885L3MBTL1 1432/4885 |
| US-11046655-B2 | Compound and method for producing same | CBR3, NR5A1, NR2E3 | LMNA 4570/4885ALDH1A1 1076/4885L3MBTL1 2735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.